Total Payments
$4,104
2024 Payments
$154.27
Companies
54
Transactions
250
Medicare Patients
1,262
Medicare Billing
$326,739
Payment Breakdown by Category
Food & Beverage$4,070 (99.2%)
Education$33.76 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,070 | 248 | 99.2% |
| Education | $33.76 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $567.81 | 33 | $0 (2022) |
| Janssen Biotech, Inc. | $414.22 | 26 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $386.84 | 23 | $0 (2023) |
| INSYS Therapeutics Inc | $313.80 | 32 | $0 (2018) |
| Celgene Corporation | $248.28 | 12 | $0 (2019) |
| Boston Scientific Corporation | $219.31 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $153.34 | 11 | $0 (2024) |
| Incyte Corporation | $126.73 | 7 | $0 (2024) |
| Eisai Inc. | $103.97 | 4 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $89.45 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $154.27 | 8 | Merck Sharp & Dohme LLC ($36.65) |
| 2023 | $482.12 | 29 | Amgen Inc. ($51.33) |
| 2022 | $207.37 | 13 | Daiichi Sankyo Inc. ($43.15) |
| 2021 | $48.71 | 2 | Myovant Sciences Inc. ($28.60) |
| 2020 | $216.00 | 11 | Bayer HealthCare Pharmaceuticals Inc. ($142.03) |
| 2019 | $1,121 | 62 | Bayer HealthCare Pharmaceuticals Inc. ($181.59) |
| 2018 | $982.68 | 58 | Janssen Biotech, Inc. ($199.22) |
| 2017 | $891.74 | 67 | INSYS Therapeutics Inc ($225.88) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $26.84 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 03/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ONCOLOGY | ||||||
| 02/16/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Oncology | ||||||
| 02/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2024 | Incyte Corporation | JAKAFI (Drug), MONJUVI, PEMAZYRE | Food and Beverage | Cash or cash equivalent | $15.10 | General |
| Category: Hematology/Oncology | ||||||
| 12/15/2023 | Jazz Pharmaceuticals Inc. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/08/2023 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Oncology | ||||||
| 11/15/2023 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Oncology | ||||||
| 09/30/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 09/26/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Oncology | ||||||
| 09/19/2023 | Ipsen Biopharmaceuticals, Inc | Tazverik (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Oncology | ||||||
| 09/15/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Oncology | ||||||
| 08/18/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Oncology | ||||||
| 08/14/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/08/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $12.83 | General |
| 06/23/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: Oncology | ||||||
| 06/22/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Oncology | ||||||
| 05/26/2023 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 05/22/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Oncology | ||||||
| 05/16/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2023 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 12 | 233 | 934 | $192,848 | $57,506 |
| 2020 | 19 | 1,029 | 3,810 | $914,632 | $269,233 |
Total Patients
1,262
Total Services
4,744
Medicare Billing
$326,739
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Facility | 2021 | 30 | 433 | $51,527 | $15,499 | 30.1% |
| 77427 | Radiation treatment management, 5 treatments | Facility | 2021 | 30 | 97 | $48,985 | $14,257 | 29.1% |
| 77301 | Management of modulation radiotherapy planning | Facility | 2021 | 16 | 18 | $20,214 | $6,013 | 29.7% |
| 77300 | Calculation of radiation therapy dose | Facility | 2021 | 26 | 193 | $16,984 | $5,060 | 29.8% |
| 77338 | Design and construction of device for radiation therapy | Facility | 2021 | 16 | 18 | $10,962 | $3,256 | 29.7% |
| 77334 | Radiation treatment devices, design and construction, complex | Facility | 2021 | 21 | 66 | $11,418 | $3,174 | 27.8% |
| 77295 | Management of radiation therapy, 3d | Facility | 2021 | 14 | 17 | $6,290 | $2,913 | 46.3% |
| 77263 | Management of radiation therapy, complex | Facility | 2021 | 21 | 21 | $9,513 | $2,584 | 27.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 16 | 16 | $8,816 | $2,247 | 25.5% |
| 77290 | Management of radiation therapy, simulation, complex | Facility | 2021 | 17 | 25 | $5,475 | $1,646 | 30.1% |
| 77280 | Management of radiation therapy simulation, simple | Facility | 2021 | 14 | 18 | $1,764 | $550.08 | 31.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 12 | 12 | $900.00 | $308.18 | 34.2% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Facility | 2020 | 92 | 1,619 | $192,661 | $59,049 | 30.6% |
| 77427 | Radiation treatment management, 5 treatments | Facility | 2020 | 92 | 363 | $183,315 | $55,965 | 30.5% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2020 | 12 | 12 | $120,252 | $30,251 | 25.2% |
| 77301 | Management of modulation radiotherapy planning | Facility | 2020 | 48 | 63 | $70,749 | $21,251 | 30.0% |
| 77300 | Calculation of radiation therapy dose | Facility | 2020 | 94 | 726 | $63,888 | $19,167 | 30.0% |
| 77263 | Management of radiation therapy, complex | Facility | 2020 | 107 | 116 | $52,548 | $15,746 | 30.0% |
| 77334 | Radiation treatment devices, design and construction, complex | Facility | 2020 | 102 | 304 | $52,592 | $14,774 | 28.1% |
| 77338 | Design and construction of device for radiation therapy | Facility | 2020 | 48 | 63 | $38,367 | $11,484 | 29.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 86 | 86 | $47,386 | $11,286 | 23.8% |
| 77295 | Management of radiation therapy, 3d | Facility | 2020 | 51 | 62 | $22,940 | $11,192 | 48.8% |
| 77290 | Management of radiation therapy, simulation, complex | Facility | 2020 | 63 | 91 | $19,929 | $6,105 | 30.6% |
| 77470 | Special radiation treatment procedure | Facility | 2020 | 40 | 41 | $7,544 | $3,534 | 46.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 66 | 92 | $17,756 | $3,326 | 18.7% |
About Dr. Randy Sorum, M.D
Dr. Randy Sorum, M.D is a Radiation Oncology healthcare provider based in Sioux City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720059181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randy Sorum, M.D has received a total of $4,104 in payments from pharmaceutical and medical device companies, with $154.27 received in 2024. These payments were reported across 250 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($4,070).
As a Medicare-enrolled provider, Sorum has provided services to 1,262 Medicare beneficiaries, totaling 4,744 services with total Medicare billing of $326,739. Data is available for 2 years (2020–2021), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology
- Location Sioux City, IA
- Active Since 02/01/2006
- Last Updated 11/08/2024
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1720059181
Products in Payments
- Xofigo (Drug) $528.87
- SUBSYS (Drug) $284.02
- DARZALEX (Biological) $158.14
- Abraxane (Drug) $127.58
- JAKAFI (Drug) $126.73
- Erleada (Drug) $123.64
- GENERAL ONCOLOGY (Device) $112.23
- ZYTIGA (Drug) $104.71
- Lenvima (Drug) $103.97
- CALQUENCE (Drug) $97.17
- Revlimid (Drug) $92.95
- Tavalisse (Drug) $89.45
- KEYTRUDA (Biological) $88.21
- IMFINZI (Drug) $82.85
- FASLODEX (Drug) $76.33
- AFINITOR (Drug) $65.54
- Versa HD (Device) $54.26
- TAGRISSO (Drug) $52.01
- SpaceOAR VUE System - 10mL (Device) $49.66
- PROVENGE (Drug) $45.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.